vs

Side-by-side financial comparison of Ainos, Inc. (AIMD) and Arrive AI Inc. (ARAI). Click either name above to swap in a different company.

Ainos, Inc. is the larger business by last-quarter revenue ($106.2K vs $90.7K, roughly 1.2× Arrive AI Inc.). Ainos, Inc. runs the higher net margin — -3094.0% vs -4066.2%, a 972.2% gap on every dollar of revenue.

Ainos, Inc. is a biotechnology firm specializing in the development and commercialization of portable point-of-care diagnostic testing solutions. Its product portfolio includes infectious disease detection kits, hormone testing tools, and general health screening products, serving clinical, consumer, and public health segments across North America, Europe, and the Asia-Pacific.

Arrive AI Inc. develops and delivers AI-powered logistics and supply chain optimization solutions. Its core offerings include intelligent route planning, automated load matching, and operational efficiency tools targeted at e-commerce merchants, freight forwarders, and small-to-medium logistics operators across the North American market, helping cut operational costs and shorten delivery cycles.

AIMD vs ARAI — Head-to-Head

Bigger by revenue
AIMD
AIMD
1.2× larger
AIMD
$106.2K
$90.7K
ARAI
Higher net margin
AIMD
AIMD
972.2% more per $
AIMD
-3094.0%
-4066.2%
ARAI

Income Statement — Q1 FY2025 vs Q2 FY2025

Metric
AIMD
AIMD
ARAI
ARAI
Revenue
$106.2K
$90.7K
Net Profit
$-3.3M
$-3.7M
Gross Margin
82.8%
Operating Margin
-2978.0%
-4066.2%
Net Margin
-3094.0%
-4066.2%
Revenue YoY
412.4%
Net Profit YoY
0.9%
EPS (diluted)
$-0.21
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIMD
AIMD
ARAI
ARAI
Q2 25
$90.7K
Q1 25
$106.2K
Q3 24
$0
Q2 24
$0
Q1 24
$20.7K
Net Profit
AIMD
AIMD
ARAI
ARAI
Q2 25
$-3.7M
Q1 25
$-3.3M
Q3 24
$-3.7M
Q2 24
$-3.2M
Q1 24
$-3.3M
Gross Margin
AIMD
AIMD
ARAI
ARAI
Q2 25
Q1 25
82.8%
Q3 24
Q2 24
Q1 24
Operating Margin
AIMD
AIMD
ARAI
ARAI
Q2 25
-4066.2%
Q1 25
-2978.0%
Q3 24
Q2 24
Q1 24
-15051.8%
Net Margin
AIMD
AIMD
ARAI
ARAI
Q2 25
-4066.2%
Q1 25
-3094.0%
Q3 24
Q2 24
Q1 24
-15991.2%
EPS (diluted)
AIMD
AIMD
ARAI
ARAI
Q2 25
$-0.12
Q1 25
$-0.21
Q3 24
$-1.64
Q2 24
$-2.45
Q1 24
$-0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIMD
AIMD
ARAI
ARAI
Cash + ST InvestmentsLiquidity on hand
$2.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$13.1M
$4.5M
Total Assets
$26.4M
$8.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIMD
AIMD
ARAI
ARAI
Q2 25
Q1 25
$2.6M
Q3 24
$5.2M
Q2 24
$8.0M
Q1 24
$1.0M
Stockholders' Equity
AIMD
AIMD
ARAI
ARAI
Q2 25
$4.5M
Q1 25
$13.1M
Q3 24
$18.0M
Q2 24
$20.7M
Q1 24
$22.7M
Total Assets
AIMD
AIMD
ARAI
ARAI
Q2 25
$8.5M
Q1 25
$26.4M
Q3 24
$31.4M
Q2 24
$35.5M
Q1 24
$29.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIMD
AIMD
ARAI
ARAI
Operating Cash FlowLast quarter
$-1.2M
$-3.3M
Free Cash FlowOCF − Capex
$-1.3M
FCF MarginFCF / Revenue
-1184.7%
Capex IntensityCapex / Revenue
31.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIMD
AIMD
ARAI
ARAI
Q2 25
$-3.3M
Q1 25
$-1.2M
Q3 24
$-1.5M
Q2 24
$-2.0M
Q1 24
$-1.5M
Free Cash Flow
AIMD
AIMD
ARAI
ARAI
Q2 25
Q1 25
$-1.3M
Q3 24
$-1.5M
Q2 24
$-2.0M
Q1 24
$-1.5M
FCF Margin
AIMD
AIMD
ARAI
ARAI
Q2 25
Q1 25
-1184.7%
Q3 24
Q2 24
Q1 24
-7232.3%
Capex Intensity
AIMD
AIMD
ARAI
ARAI
Q2 25
Q1 25
31.7%
Q3 24
Q2 24
Q1 24
21.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons